IFNB1 and myeloid sarcoma: However, enhancing the ability of Tregs to maintain self-tolerance appears to be an alternative therapy for MS clinically and includes IFN-β, glatiramer acetate (GA; Copaxone), fingolimod (Gilenya), and teriflunomide (Aubagio) [71, 73].